Relay Therapeutics
Tom Catinazzo brings to Relay more than 12 years of extensive experience in the biotechnology field. Prior to Relay, he was vice president of financial planning and analysis at Foundation Medicine, where he was responsible for overseeing all aspects business planning functions. Previously, Tom worked at Aileron Therapeutics, as well as Genzyme Corporation, supporting both the renal and personalized genetic health division.
Tom holds a B.S. from Boston College.
Relay Therapeutics
1 followers
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology.